Detalhe da pesquisa
1.
Open-Label Study To Evaluate the Single-Dose Pharmacokinetics, Safety, and Tolerability of Doripenem in Infants Less than 12 Weeks in Chronological Age.
Antimicrob Agents Chemother
; 59(8): 4742-9, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26014957
2.
A randomized trial of 7-day doripenem versus 10-day imipenem-cilastatin for ventilator-associated pneumonia.
Crit Care
; 16(6): R218, 2012 Nov 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-23148736
3.
Influence of continuous venovenous hemofiltration and continuous venovenous hemodiafiltration on the disposition of doripenem.
Antimicrob Agents Chemother
; 55(3): 1187-93, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21199922
4.
Pharmacokinetics, safety, and tolerability of doripenem after 0.5-, 1-, and 4-hour infusions in healthy volunteers.
J Clin Pharmacol
; 49(7): 798-806, 2009 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-19553404
5.
Disposition, metabolism, and excretion of [14C]doripenem after a single 500-milligram intravenous infusion in healthy men.
Antimicrob Agents Chemother
; 52(10): 3478-83, 2008 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-18644951
6.
Safety and Tolerability of Doripenem in Hospitalized Children With Complicated Intra-Abdominal Infection, Complicated Urinary Tract Infections and Pneumonia.
Pediatr Infect Dis J
; 34(11): 1264-7, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26226440
7.
The effect of food on the pharmacokinetics of a dual angiotensin-converting enzyme/neutral endopeptidase inhibitor, M100240.
J Clin Pharmacol
; 44(12): 1379-84, 2004 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-15545308
8.
No clinically relevant CYP3A induction with the dual angiotensin-converting enzyme/neutral endopeptidase inhibitor, M100240.
J Clin Pharmacol
; 44(4): 379-87, 2004 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-15051745
9.
Pharmacokinetics of single-dose doripenem in adults with cystic fibrosis.
J Clin Pharmacol
; 52(11): 1645-53, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22174436
10.
Doripenem dosing recommendations for critically ill patients receiving continuous renal replacement therapy.
ISRN Pharmacol
; 2012: 782656, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22888451